Maxion Therapeutics raised €15M in a Series A round in Feb 2023. The company is based in Cambridge, UK. Investors in the round: BGF, LifeArc Ventures, Monograph Capital. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
